Immix Biopharma, Inc.
IMMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873835
No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Immix Biopharma, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- +11 vs. Q3 2021
- Shares held
- 1.54M
- +1.54M vs. Q3 2021
- Total value
- $5.47M
- +$5.47M vs. Q3 2021
- New holders
- 11
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 109 | $579.6M |
| Q1 2026 | 77 | $246.6M |
| Q4 2025 | 67 | $127.5M |
| Q3 2025 | 31 | $5.78M |
| Q2 2025 | 23 | $4.68M |
| Q1 2025 | 22 | $4.90M |
| Q4 2024 | 23 | $6.32M |
| Q3 2024 | 25 | $6.10M |
| Q2 2024 | 31 | $8.77M |
| Q1 2024 | 35 | $15.7M |
| Q4 2023 | 28 | $5.32M |
| Q3 2023 | 16 | $1.39M |
| Q2 2023 | 18 | $1.75M |
| Q1 2023 | 12 | $729.8K |
| Q4 2022 | 18 | $1.01M |
| Q3 2022 | 12 | $406.0K |
| Q2 2022 | 7 | $475.0K |
| Q1 2022 | 8 | $352.0K |
| Q4 2021 | 11 | $5.47M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Immix Biopharma, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Murchinson Ltd. | 695,600 | $2.48M | 0.24% | +695,600 | New |
| Lynwood Capital Management Inc. | 565,297 | $2.01M | 1.93% | +565,297 | New |
| Altium Capital Management LP | 122,388 | $436.0K | 0.12% | +122,388 | New |
| UBS Group AG | 32,649 | $116.0K | 0.00% | +32,649 | New |
| Eidelman Virant Capital | 29,856 | $103.0K | 0.04% | +29,856 | New |
| Citadel Advisors LLC | 26,474 | $94.0K | 0.00% | +26,474 | New |
| Millennium Management LLC | 20,470 | $73.0K | 0.00% | +20,470 | New |
| PVG Asset Management Corp | 20,000 | $71.2K | 0.26% | +20,000 | New |
| Two Sigma Securities, LLC | 13,173 | $47.0K | 0.01% | +13,173 | New |
| Context Capital Management, LLC | 11,532 | $41.0K | 0.00% | +11,532 | New |
| Clear Street LLC | 1,000 | $4.00K | 0.00% | +1,000 | New |